Goldman Sachs buys stake in Indian research firm
Says it is ‘well positioned to benefit from increased outsourcing by the life sciences industry’
Says it is ‘well positioned to benefit from increased outsourcing by the life sciences industry’
Strong Q1 figures belie significant stock market corrections and less fiscally accommodative government policy
Geopolitics, structural change and the vaccine rollout will have varying impacts
They could be a potential source of income ‘where many assets have stretched valuations and tight spreads’
It invests in companies with at least two-thirds of net assets based in Asia ex-Japan
With so much attention on the rise of China, many investors often overlook India
Emerging markets and small caps predicted to outperform large caps and developed markets
‘Identifying countries that are at the foothills of a change in fortunes can be powerful’
Pharma industry expected to play a big part in global vaccination push
A flexible fund investing across emerging bond markets. Watch the Talking Factsheet for the M&G Emerging Markets Bond fund with Eduardo Sanchez, Senior Investment Research Analyst.
‘Spreading your investments increases the chances of mitigating the drag of any stragglers’
Could the Cold War offer any clues about what lies ahead?